{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:31:00Z","timestamp":1789129860063,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.acvd.2019.11.007","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T08:37:04Z","timestamp":1582706224000},"page":"209-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Durability of transcatheter aortic valve implantation: A translational review"],"prefix":"10.1016","volume":"113","author":[{"given":"Charles","family":"Fauvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7233-7409","authenticated-orcid":false,"given":"Romain","family":"Capoulade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine M.","family":"B\u00e9ziau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Le Tourneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Eltchaninoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2019.11.007_bib0430","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000047200.36165.B8","article-title":"Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description","volume":"106","author":"Cribier","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0435","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/eurheartj\/ehy107","article-title":"Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections","volume":"39","author":"Durko","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.11.007_bib0440","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","article-title":"Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Vahanian","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.acvd.2019.11.007_bib0445","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.11.007_bib0450","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0455","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0460","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/eurheartj\/ehx303","volume":"38","author":"Capodanno","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.11.007_bib0465","first-page":"982","article-title":"Basic mechanisms of calcific aortic valve disease","volume":"30","author":"Mathieu","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0470","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcmg.2019.01.027","article-title":"Determinants of bioprosthetic aortic valve degeneration","volume":"13","author":"Nitsche","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2019.11.007_bib0475","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCRESAHA.113.300155","article-title":"Molecular and cellular aspects of calcific aortic valve disease","volume":"113","author":"Towler","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2019.11.007_bib0480","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.athoracsur.2014.10.070","article-title":"Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants","volume":"99","author":"Johnston","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.acvd.2019.11.007_bib0485","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.athoracsur.2013.03.032","article-title":"Carpentier-Edwards pericardial valve in the aortic position: 25-years experience","volume":"96","author":"Forcillo","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.acvd.2019.11.007_bib0490","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.114.010400","article-title":"Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients","volume":"130","author":"Senage","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0495","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.030729","article-title":"Standardised definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves","volume":"137","author":"Dvir","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0500","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.acvd.2019.11.007_bib0505","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2012.03.052","article-title":"Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy","volume":"60","author":"Capoulade","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0510","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/eci.12169","article-title":"Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis","volume":"43","author":"Capoulade","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.acvd.2019.11.007_bib0515","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomised trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0520","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","article-title":"Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies","volume":"111","author":"Freeman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0525","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0530","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0535","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","article-title":"Calcific aortic stenosis: a disease of the valve and the myocardium","volume":"60","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0540","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fcvm.2018.00162","article-title":"The genetic regulation of aortic valve development and calcific disease","volume":"5","author":"Menon","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0545","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0550","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2016.11.010","article-title":"Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: the EPIC-Norfolk prospective population study","volume":"256","author":"Perrot","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2019.11.007_bib0555","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidised phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0560","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/jamacardio.2018.3798","article-title":"Association of mild to moderate aortic valve stenosis progression with higher lipoprotein(a) and oxidised phospholipid levels: secondary analysis of a randomised clinical trial","volume":"3","author":"Capoulade","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0565","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0570","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/14779072.2017.1367286","article-title":"Pathobiology of Lp(a) in calcific aortic valve disease","volume":"15","author":"Mathieu","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.acvd.2019.11.007_bib0575","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/ATVBAHA.116.308761","article-title":"Oxidised phospholipids and risk of calcific aortic valve disease: the Copenhagen general population study","volume":"37","author":"Kamstrup","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0580","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1038\/s41586-018-0313-x","article-title":"Publisher correction: oxidised phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"561","author":"Que","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2019.11.007_bib0585","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralisation of the aortic valve","volume":"132","author":"Bouchareb","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0590","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcmg.2014.09.016","article-title":"Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study","volume":"8","author":"Capoulade","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2019.11.007_bib0595","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jacc.2013.08.1639","article-title":"New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidised phospholipid axis","volume":"63","author":"Hung","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0600","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jacc.2013.05.105","article-title":"Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralisation","volume":"63","author":"Mahmut","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0605","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.2353\/ajpath.2010.090541","article-title":"Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2","volume":"176","author":"Derbali","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0610","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1161\/ATVBAHA.112.300116","article-title":"Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2","volume":"32","author":"Song","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0615","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(15)61252-1","article-title":"Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study","volume":"386","author":"Tsimikas","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2019.11.007_bib0620","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.jacc.2018.09.063","article-title":"PCSK9 involvement in aortic valve calcification","volume":"72","author":"Poggio","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0625","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10753-012-9579-6","article-title":"Inflammation is associated with the remodelling of calcific aortic valve disease","volume":"36","author":"Cote","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0630","first-page":"869","article-title":"Tumour necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification","volume":"16","author":"Kaden","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0635","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcvm.2019.00018","article-title":"Autotaxin and lipoprotein metabolism in calcific aortic valve disease","volume":"6","author":"Mathieu","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0640","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/hrt.2005.086595","article-title":"Distribution of SPARC during neovascularisation of degenerative aortic stenosis","volume":"92","author":"Charest","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2019.11.007_bib0645","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2012.07.042","article-title":"Role of circulating osteogenic progenitor cells in calcific aortic stenosis","volume":"60","author":"Gossl","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0650","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCGEN.119.002617","article-title":"Genetic association analyses highlight IL6, ALPL, and NAV1 as 3 new susceptibility genes underlying calcific aortic valve stenosis","volume":"12","author":"Th\u00e9riault","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.acvd.2019.11.007_bib0655","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/CIRCULATIONAHA.108.778886","article-title":"Prosthetic heart valves: selection of the optimal prosthesis and long-term management","volume":"119","author":"Pibarot","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0660","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jacc.2017.07.715","article-title":"Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration","volume":"70","author":"Rodriguez-Gabella","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0665","doi-asserted-by":"crossref","first-page":"I512","DOI":"10.1161\/CIRCULATIONAHA.105.000422","article-title":"Metabolic syndrome is associated with faster degeneration of bioprosthetic valves","volume":"114","author":"Briand","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0670","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0022-5223(03)00708-6","article-title":"Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation","volume":"126","author":"Farivar","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.acvd.2019.11.007_bib0675","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/eurheartj\/ehs003","article-title":"The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27,186 patients with 133,141 patient-years","volume":"33","author":"Head","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.11.007_bib0680","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2012.11.033","article-title":"ApoB\/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration","volume":"61","author":"Mahjoub","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0685","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/eci.12199","article-title":"Lp-PLA2 is associated with structural valve degeneration of bioprostheses","volume":"44","author":"Mahmut","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.acvd.2019.11.007_bib0690","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1136\/heartjnl-2016-309541","article-title":"Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration","volume":"102","author":"Nsaibia","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2019.11.007_bib0695","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2018.04.064","article-title":"Hemodynamic deterioration of surgically implanted bioprosthetic aortic valves","volume":"72","author":"Salaun","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0700","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCULATIONAHA.118.035150","article-title":"Rate, timing, correlates and outcomes of hemodynamic valve deterioration after bioprosthetic surgical aortic valve replacement","volume":"138","author":"Salaun","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0705","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-5223(03)00131-4","article-title":"Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants","volume":"126","author":"Bottio","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.acvd.2019.11.007_bib0710","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000336170","article-title":"Elevated proportion of small, dense low-density lipoprotein particles and lower adiponectin blood levels predict early structural valve degeneration of bioprostheses","volume":"121","author":"Shetty","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.acvd.2019.11.007_bib0715","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2362.2009.02132.x","article-title":"Lipid-mediated inflammation and degeneration of bioprosthetic heart valves","volume":"39","author":"Shetty","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.acvd.2019.11.007_bib0720","doi-asserted-by":"crossref","first-page":"H5","DOI":"10.1152\/ajpheart.00824.2009","article-title":"Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signalling to physiology","volume":"298","author":"Rajamannan","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0725","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.CIR.90.1.323","article-title":"Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves","volume":"90","author":"Chen","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0730","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/CIRCULATIONAHA.105.549311","article-title":"Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection","volume":"114","author":"Manji","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0735","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/heartjnl-2017-312514","article-title":"Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement","volume":"104","author":"Del Trigo","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2019.11.007_bib0740","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.jacc.2017.02.051","article-title":"Bioprosthetic valve thrombosis","volume":"69","author":"Puri","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0745","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.R060582","article-title":"Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?","volume":"57","author":"Boffa","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.acvd.2019.11.007_bib0750","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2018.08.1045","article-title":"Long-term mortality and early valve dysfunction according to anticoagulation use: the FRANCE TAVI registry","volume":"73","author":"Overtchouk","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0755","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcmg.2018.06.028","article-title":"Transcatheter aortic heart valves: histological analysis providing insight to leaflet thickening and structural valve degeneration","volume":"12","author":"Sellers","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2019.11.007_bib0760","doi-asserted-by":"crossref","first-page":"e007597","DOI":"10.1161\/CIRCINTERVENTIONS.118.007597","article-title":"Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using the new European definition","volume":"12","author":"Durand","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2019.11.007_bib0765","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jacc.2015.10.097","article-title":"Incidence, timing and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry","volume":"67","author":"Del Trigo","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0770","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2018.06.045","article-title":"Soluble CD14 is associated with the structural failure of bioprostheses","volume":"485","author":"Nsaibia","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.acvd.2019.11.007_bib0775","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.surg.2011.09.027","article-title":"Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery","volume":"150","author":"Yan","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.acvd.2019.11.007_bib0780","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcmg.2018.10.023","article-title":"The role of imaging in measuring disease progression and assessing novel therapies in aortic stenosis","volume":"12","author":"Doris","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2019.11.007_bib0785","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/heartjnl-2011-300351","article-title":"Doppler echocardiographic evaluation of prosthetic valve function","volume":"98","author":"Pibarot","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2019.11.007_bib0790","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2015.06.1325","article-title":"Valvular 18F-Fluoride and 18F-Fluorodeoxyglucose uptakes predict disease progression and clinical outcome in patients with aortic stenosis","volume":"66","author":"Jenkins","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0795","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41467-018-03260-6","article-title":"A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis","volume":"9","author":"Theriault","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.acvd.2019.11.007_bib0800","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.athoracsur.2014.09.030","article-title":"Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position","volume":"99","author":"Bourguignon","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.acvd.2019.11.007_bib0805","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2019.11.007_bib0810","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jcin.2015.03.024","article-title":"5-year outcomes after transcatheter aortic valve implantation with corevalve prosthesis","volume":"8","author":"Barbanti","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2019.11.007_bib0815","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/eurheartj\/ehq406","article-title":"Standardised endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium","volume":"32","author":"Leon","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.11.007_bib0820","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jacc.2012.11.010","article-title":"5-year outcome after transcatheter aortic valve implantation","volume":"61","author":"Toggweiler","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0825","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1161\/CIRCULATIONAHA.118.036866","article-title":"Five-year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients","volume":"138","author":"Didier","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.11.007_bib0830","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4244\/EIJ-D-18-00015","article-title":"Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition","volume":"14","author":"Eltchaninoff","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2019.11.007_bib0835","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4244\/EIJ-D-17-00603","article-title":"Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices","volume":"14","author":"Deutsch","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2019.11.007_bib0840","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.4244\/EIJ-D-18-00041","article-title":"Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure","volume":"14","author":"Holy","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2019.11.007_bib0845","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jacc.2018.10.078","article-title":"Long-term durability of transcatheter aortic valve prostheses","volume":"73","author":"Blackman","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.11.007_bib0850","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacc.2018.10.083","article-title":"Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk","volume":"73","author":"Sondergaard","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213620300231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213620300231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:46:13Z","timestamp":1761745573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213620300231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1875213620300231"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2019.11.007","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Durability of transcatheter aortic valve implantation: A translational review","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2019.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}